Discover how rheumatoid arthritis advances through distinct stages, the symptoms at each phase, and treatment approaches that ...

The interplay between cortisol, inflammation, and disease underscores the need for effective stress management to enhance ...

CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin -- Phase 1 study in healthy volunteers ongoing -HAMPTON, N.J., ...

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential ...

TBI occurs when the brain is damaged by an external force, like a nasty tackle or a hard punch (or getting pulled over by ...

The relationship between food allergies and chronic illness represents one of the most significant yet underappreciated ...

Therapeutics announced positive preclinical data from CDX-622, a novel bispecific antibody that targets two non-redundant, ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...

This type of antibody circulates in the blood, can recognize potential pathogens, and can drive inflammation. She sequenced these antibody-coated bacteria to identify which ones were associated ...

About CDX-622CDX-622 is a bispecific antibody that targets two complementary, clinically validated pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal ...